Report cover image

Global Indocyanine Green Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 194 Pages
SKU # APRC20355747

Description

Summary

According to APO Research, The global Indocyanine Green market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Indocyanine Green is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Indocyanine Green is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Indocyanine Green is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Indocyanine Green is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Indocyanine Green include Aurolab, Cellbion, Daiichi Sankyo Company, Diagnostic Green, Jeil Pharmaceutical, McKesson Corp, OriFarm, Pulsion Medical Systems AG and SERB, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Indocyanine Green, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Indocyanine Green, also provides the sales of main regions and countries. Of the upcoming market potential for Indocyanine Green, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Indocyanine Green sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Indocyanine Green market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Indocyanine Green sales, projected growth trends, production technology, application and end-user industry.

Indocyanine Green Segment by Company

Aurolab
Cellbion
Daiichi Sankyo Company
Diagnostic Green
Jeil Pharmaceutical
McKesson Corp
OriFarm
Pulsion Medical Systems AG
SERB
Santen Pharmaceutical
Dandong Yichuang Pharmaceutical
Eisai
Indocyanine Green Segment by Type

25mg
50mg
Indocyanine Green Segment by Application

Liver Diseases
Neurosurgery
Ophthalmology
Others
Indocyanine Green Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indocyanine Green market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Indocyanine Green and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indocyanine Green.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Indocyanine Green market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Indocyanine Green manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Indocyanine Green in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Indocyanine Green in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Indocyanine Green Market Size, 2020 VS 2024 VS 2031
1.3 Global Indocyanine Green Market Size Estimates and Forecasts (2020-2031)
1.4 Global Indocyanine Green Sales Estimates and Forecasts (2020-2031)
1.5 Global Indocyanine Green Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Indocyanine Green Market Dynamics
2.1 Indocyanine Green Industry Trends
2.2 Indocyanine Green Industry Drivers
2.3 Indocyanine Green Industry Opportunities and Challenges
2.4 Indocyanine Green Industry Restraints
3 Indocyanine Green Market by Manufacturers
3.1 Global Indocyanine Green Revenue by Manufacturers (2020-2025)
3.2 Global Indocyanine Green Sales by Manufacturers (2020-2025)
3.3 Global Indocyanine Green Average Sales Price by Manufacturers (2020-2025)
3.4 Global Indocyanine Green Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Indocyanine Green Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Indocyanine Green Manufacturers, Product Type & Application
3.7 Global Indocyanine Green Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Indocyanine Green Market CR5 and HHI
3.8.2 Global Top 5 and 10 Indocyanine Green Players Market Share by Revenue in 2024
3.8.3 2024 Indocyanine Green Tier 1, Tier 2, and Tier 3
4 Indocyanine Green Market by Type
4.1 Indocyanine Green Type Introduction
4.1.1 25mg
4.1.2 50mg
4.2 Global Indocyanine Green Sales by Type
4.2.1 Global Indocyanine Green Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Indocyanine Green Sales by Type (2020-2031)
4.2.3 Global Indocyanine Green Sales Market Share by Type (2020-2031)
4.3 Global Indocyanine Green Revenue by Type
4.3.1 Global Indocyanine Green Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Indocyanine Green Revenue by Type (2020-2031)
4.3.3 Global Indocyanine Green Revenue Market Share by Type (2020-2031)
5 Indocyanine Green Market by Application
5.1 Indocyanine Green Application Introduction
5.1.1 Liver Diseases
5.1.2 Neurosurgery
5.1.3 Ophthalmology
5.1.4 Others
5.2 Global Indocyanine Green Sales by Application
5.2.1 Global Indocyanine Green Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Indocyanine Green Sales by Application (2020-2031)
5.2.3 Global Indocyanine Green Sales Market Share by Application (2020-2031)
5.3 Global Indocyanine Green Revenue by Application
5.3.1 Global Indocyanine Green Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Indocyanine Green Revenue by Application (2020-2031)
5.3.3 Global Indocyanine Green Revenue Market Share by Application (2020-2031)
6 Global Indocyanine Green Sales by Region
6.1 Global Indocyanine Green Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Indocyanine Green Sales by Region (2020-2031)
6.2.1 Global Indocyanine Green Sales by Region (2020-2025)
6.2.2 Global Indocyanine Green Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Indocyanine Green Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Indocyanine Green Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Indocyanine Green Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Indocyanine Green Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Indocyanine Green Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Indocyanine Green Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Indocyanine Green Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Indocyanine Green Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Indocyanine Green Revenue by Region
7.1 Global Indocyanine Green Revenue by Region
7.1.1 Global Indocyanine Green Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Indocyanine Green Revenue by Region (2020-2025)
7.1.3 Global Indocyanine Green Revenue by Region (2026-2031)
7.1.4 Global Indocyanine Green Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Indocyanine Green Revenue (2020-2031)
7.2.2 North America Indocyanine Green Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Indocyanine Green Revenue (2020-2031)
7.3.2 Europe Indocyanine Green Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Indocyanine Green Revenue (2020-2031)
7.4.2 Asia-Pacific Indocyanine Green Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Indocyanine Green Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Indocyanine Green Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Aurolab
8.1.1 Aurolab Comapny Information
8.1.2 Aurolab Business Overview
8.1.3 Aurolab Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Aurolab Indocyanine Green Product Portfolio
8.1.5 Aurolab Recent Developments
8.2 Cellbion
8.2.1 Cellbion Comapny Information
8.2.2 Cellbion Business Overview
8.2.3 Cellbion Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Cellbion Indocyanine Green Product Portfolio
8.2.5 Cellbion Recent Developments
8.3 Daiichi Sankyo Company
8.3.1 Daiichi Sankyo Company Comapny Information
8.3.2 Daiichi Sankyo Company Business Overview
8.3.3 Daiichi Sankyo Company Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Daiichi Sankyo Company Indocyanine Green Product Portfolio
8.3.5 Daiichi Sankyo Company Recent Developments
8.4 Diagnostic Green
8.4.1 Diagnostic Green Comapny Information
8.4.2 Diagnostic Green Business Overview
8.4.3 Diagnostic Green Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Diagnostic Green Indocyanine Green Product Portfolio
8.4.5 Diagnostic Green Recent Developments
8.5 Jeil Pharmaceutical
8.5.1 Jeil Pharmaceutical Comapny Information
8.5.2 Jeil Pharmaceutical Business Overview
8.5.3 Jeil Pharmaceutical Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Jeil Pharmaceutical Indocyanine Green Product Portfolio
8.5.5 Jeil Pharmaceutical Recent Developments
8.6 McKesson Corp
8.6.1 McKesson Corp Comapny Information
8.6.2 McKesson Corp Business Overview
8.6.3 McKesson Corp Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 McKesson Corp Indocyanine Green Product Portfolio
8.6.5 McKesson Corp Recent Developments
8.7 OriFarm
8.7.1 OriFarm Comapny Information
8.7.2 OriFarm Business Overview
8.7.3 OriFarm Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 OriFarm Indocyanine Green Product Portfolio
8.7.5 OriFarm Recent Developments
8.8 Pulsion Medical Systems AG
8.8.1 Pulsion Medical Systems AG Comapny Information
8.8.2 Pulsion Medical Systems AG Business Overview
8.8.3 Pulsion Medical Systems AG Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Pulsion Medical Systems AG Indocyanine Green Product Portfolio
8.8.5 Pulsion Medical Systems AG Recent Developments
8.9 SERB
8.9.1 SERB Comapny Information
8.9.2 SERB Business Overview
8.9.3 SERB Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 SERB Indocyanine Green Product Portfolio
8.9.5 SERB Recent Developments
8.10 Santen Pharmaceutical
8.10.1 Santen Pharmaceutical Comapny Information
8.10.2 Santen Pharmaceutical Business Overview
8.10.3 Santen Pharmaceutical Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Santen Pharmaceutical Indocyanine Green Product Portfolio
8.10.5 Santen Pharmaceutical Recent Developments
8.11 Dandong Yichuang Pharmaceutical
8.11.1 Dandong Yichuang Pharmaceutical Comapny Information
8.11.2 Dandong Yichuang Pharmaceutical Business Overview
8.11.3 Dandong Yichuang Pharmaceutical Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Dandong Yichuang Pharmaceutical Indocyanine Green Product Portfolio
8.11.5 Dandong Yichuang Pharmaceutical Recent Developments
8.12 Eisai
8.12.1 Eisai Comapny Information
8.12.2 Eisai Business Overview
8.12.3 Eisai Indocyanine Green Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Eisai Indocyanine Green Product Portfolio
8.12.5 Eisai Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Indocyanine Green Value Chain Analysis
9.1.1 Indocyanine Green Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Indocyanine Green Production Mode & Process
9.2 Indocyanine Green Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Indocyanine Green Distributors
9.2.3 Indocyanine Green Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.